SocraTec R&D Concepts in Drug Research and Development
SocraTec R&D Concepts in Drug Research and Development is recorded as a service provider in 9 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 9 of 9 trials · Latest update first
A Randomized, Open label, Single Center, Single Oral Dose, Four Treatment, Four Period, Four Sequence, Crossover Bioavailability Study of Haleon Immediate Release Tablets 2X (paracetamol/naproxen 500 mg/125 mg) vs. Panadol Advance Tablets 2X (paracetamol 500 mg), Naprosyn Tablets 1X (naproxen 250 mg), administered individually in fasted conditions and Haleon Immediate Release Tablets 2X (paracetamol/naproxen 500 mg/125 mg) in fed conditions in Healthy Adult Participants
Sponsor Haleon CH SARL
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of an Esflurbiprofen Topical System (EFTS) vs. placebo in the local symptomatic and short-term treatment of pain in ankle sprains.
Sponsor Teikoku Seiyaku Co. Ltd.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available1 trial-level finding · Read insights
- Five German sites enrolled 70 participants between March and October 2025.
These findings describe the trial, not the service provider’s performance or responsibility.
An open label, multi-centric trial to assess the safety and efficacy of an Esflurbiprofen Topical System (EFTS) in the local symptomatic and short-term treatment of pain in contusions.
Sponsor Teikoku Seiyaku Co. Ltd.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available1 trial-level finding · Read insights
- Five sites in Germany enrolled 221 participants between February and October 2025.
These findings describe the trial, not the service provider’s performance or responsibility.
TherVacB – A multi-center phase 1b/2a trial to assess safety, tolerability and immunogenicity of a heterologous protein prime/MVA boost therapeutic hepatitis B vaccine candidate
Sponsor Klinikum der Universitaet Muenchen AöR
- Start (EU)
- Latest update
- Estimated end
A single-centre, Phase 2, open-label study to investigate ovulation inhibition after the administration of different dosages of dienogest tablets in combination with different dosages of drospirenone tablets with regular intake and after intentional intake errors in healthy premenopausal female participants
Sponsor Gedeon Richter Plc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low-Grade Upper Tract Urothelial Cancer
Sponsor Steba Biotech S.A.
- Start (EU)
- Latest update
- Estimated end
A single-centre, open-label, randomised, phase II study on the maintenance of ovulation inhibition after intentional application errors during 84 days of treatment with MR-130A-01 contraceptive transdermal patch
Sponsor Mylan Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 1b/2a, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MB-001 in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor Mage Biologics Inc.
- Start (EU)
- Latest update
- Estimated end
Randomized, controlled, open-label, multi-center trial to compare the efficacy and safety of three herbal medicinal products in the treatment of acute bronchitis
Sponsor Engelhard Arzneimittel GmbH & Co. KG
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for SocraTec R&D Concepts in Drug Research and Development?
The 2026-10-09 snapshot links SocraTec R&D Concepts in Drug Research and Development to 9 distinct CTIS trials. Recorded services include Project management, Regulatory services, Clinical monitoring, Medical writing, among 10 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for SocraTec R&D Concepts in Drug Research and Development?
The most frequently recorded therapeutic areas are Musculoskeletal, Pain Medicine, Trauma and Injury, Gynecology. Recorded phases include Phase 3, Phase 2, Phase 1. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to SocraTec R&D Concepts in Drug Research and Development conducted?
The linked trials record locations in 6 countries, including Germany, Spain, Austria, France, Italy. These are trial locations, not confirmed office locations or countries where SocraTec R&D Concepts in Drug Research and Development delivered services.
What can this page tell me about SocraTec R&D Concepts in Drug Research and Development's trial experience?
Browse 9 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 2 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under SocraTec R&D Concepts in Drug Research and Development. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- SocraTec R&D Concepts in Drug Research and Development GmbH